ABCB1 and cancer: In this study, we surveyed the connection of ARS-1620 with ABCB1-overexpressing cancer cells and we found that the overexpression of ABCB1 confers resistance to ARS-1620, which may affect its effectiveness in clinical anticancer treatments.